BioNxt Reports Expanded Research, Development and Commercialization Capability with Centralized Munich Laboratory
VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, is pleased to announce the integration of its research, development and commercialization activities to the Gen-Plus GmbH & Co. KG (Gen-Plus) Contract Research and Development Organization (CRDO) in Munich, Germany. The move provides BioNxt with enhanced R&D capabilities, collaboration opportunities, and accelerated innovation potential within a major European biotech hub.
The Company seeks to leverage the advanced and innovative infrastructure of the Gen-Plus Laboratory and harness the facility's 1,000 square meters of state-of-the-art space designed for high-potency active pharmaceutical ingredients and GMP-compliant processes. The lab's specialized equipment, including advanced technologies for solid and semi-solid dosage forms and capabilities in drug printing, will empower BioNxt to maximize the potential of its proprietary drug delivery systems, neurodegenerative disease therapeutics, and next-generation biomedical technologies.
In the coming weeks, BioNxt and Gen-Plus will be working together closely and focused on the development and commercialization of the Company's lead product, BNT23001, a sublingual thin-film formulation of Cladribine for the treatment of multiple sclerosis (MS). Preparation activities for the planned human bioequivalence study include placebo trials, product and technology transfer, upscaling of manufacturing, and analytical validation of the active pharmaceutical ingredient.
About Gen-Plus GmbH & Co. KG
Gen-Plus, headquartered in Munich, Germany, is a premier Contract Research and Development Organization (CRDO) with over 25 years of experience in pharmaceutical formulation and development. The company operates a 1,000-square-meter state-of-the-art laboratory equipped for handling high-potency active pharmaceutical ingredients and licensed for GMP-compliant production, including narcotics.
Gen-Plus specializes in developing solid and semi-solid dosage forms, transdermal patches, and oral thin films, offering end-to-end services from feasibility studies to clinical trial supply production. The company leverages advanced technologies such as hot-melt extrusion, drug printing, and amorphization of APIs to deliver comprehensive pharmaceutical solutions.
Committed to innovation, Gen-Plus collaborates with leading European research institutions and biotech companies to drive advancements in pharmaceutical solutions. The company's expertise and cutting-edge infrastructure make it a trusted partner in accelerating drug development and commercialization.
About BioNxt Solutions Inc.
BioNxt Solutions Inc. is a bioscience innovator focused on next-generation drug delivery technologies, diagnostic screening systems, and active pharmaceutical ingredient development. The Company's proprietary platforms-Sublingual (Thin-Film), Transdermal (Skin Patch), and Oral (Enteric-Coated Tablets)-target key therapeutic areas, including autoimmune diseases, neurological disorders, and longevity.
With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. BioNxt is committed to improving healthcare by delivering precise, patient-centric solutions that enhance treatment outcomes worldwide.
BioNxt is listed on the Canadian Securities Exchange: BNXT, OTC Markets: BNXTF and trades in Germany under WKN: A3D1K3. To learn more about BioNxt, please visit www.bionxt.com.
Investor Relations & Media Contact
Hugh Rogers, Co-Founder, CEO and Director
Email: investor.relations@bionxt.com
Phone: +1 778.598.2698
Web: www.bionxt.com
LinkedIn: https://www.linkedin.com/company/bionxt-solutions
Instagram: https://www.instagram.com/bionxt
Cautionary Statement Regarding "Forward-Looking" Information
This press release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information is based on management's expectations, estimates, projections, and assumptions as of the date of this press release. It is subject to significant risks, uncertainties, and other factors that could cause actual results or events to differ materially from those expressed or implied. These risks and uncertainties include, but are not limited to, general economic conditions, market conditions, regulatory risks, technological advancements, and other factors described in the Company's public disclosure filings.
Readers are cautioned not to place undue reliance on forward-looking information, as actual outcomes may differ significantly from those expressed or implied, due to various factors beyond the Company's control. The Company undertakes no obligation to update or revise any forward-looking information, except as required by law.
SOURCE: BioNxt Solutions Inc.
View the original press release on ACCESS Newswire
BioNxt Solutions Inc.
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Camino Announces High-Grade Channel Results of 7 Meters @ 4.3% Copper, 25.5 ppm Silver and 18 meters @ 1.57 % Copper and 11.35 ppm Silver at Los Chapitos in Peru17.6.2025 12:00:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / June 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce high‐grade copper channel results from the Katty prospect located in the Diva Trend, one of several prospective targets at the Company's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. A total of 12 excavated channels were completed at the prospect and all channels contained significant high-grade intercepts of copper with associated silver (Table 1). Los Chapitos is Camino's second copper project with partner Nittetsu Mining Co, Ltd. ("Nittetsu"), which can earn a 35% interest in Los Chapitos once it completes a total investment of CDN$10 Million (see news release dated June 14, 2023). Rio Tinto, a major copper producer, recently staked claims adjacent to Los Chapitos (see news release dated May 17, 2024). Camino is also advancing its mine development project, the Puquios Copper Project, with Nittetsu Mining
The 12th GLA Global Logistics Conference: A New Chapter in International Logistics Cooperation17.6.2025 05:50:00 CEST | Press release
DUBAI, AE / ACCESS Newswire / June 16, 2025 / From May 15 to 18, 2025, the 12th GLA Global Logistics Conference was held at the Grand Hyatt Dubai, shaping the future of the international logistics landscape. Organized by the Global Logistics Enterprises Federation (GLEF) and the GLA Global Logistics Alliance, the conference gathered nearly 2,000 professionals, including logistics experts, senior executives and government officials from over 130 countries and regions. This year's edition reinforced GLA's position as a central hub for strategic networking, innovation and global trade cooperation. Group Photo of the 12th GLA Global Logistics Conference Under the theme "Peaceful Prosperity · Digital Innovation · Trustworthy Cooperation," the conference reflected the logistics sector's collective ambition to respond to today's challenges, ranging from geopolitical disruptions and supply chain volatility to technological advancement and environmental demands. The Opening Ceremony of the 12th
Corsair Signs Strategic Partnership with Kera Energy for Global Distribution of Pyrolysis Oil16.6.2025 09:10:00 CEST | Press release
New partnership expands global access to Corsair's recycled plastic oil across Europe, Asia, and the Americas. AMSTERDAM, NETHERLANDS / ACCESS Newswire / June 16, 2025 / Plastic waste recycling company Corsair Group International Holding BV (CORSAIR) is proud to announce a new strategic partnership with KERA Energy AG, a Swiss-based leader in sustainable industrial value chains. Under the agreement, CORSAIR will supply advanced pyrolysis oil to KERA Energy, which will distribute the Plastic Pyrolysis Oil (PPO) across key markets in Europe, Asia, and the Americas. This collaboration marks another important step in CORSAIR's mission to scale up sustainable advanced recycling of plastic waste. The agreement with KERA Energy signals growing international demand for CORSAIR's high-quality pyrolysis oil derived from everyday household plastic waste. "We are very pleased to partner with KERA Energy, a company that shares our vision of a cleaner, circular economy," said Jussi Veikko Saloranta,
GA-ASI Announces New PELE Small UAS for International Customers16.6.2025 06:00:00 CEST | Press release
Small, Uncrewed Launched Effect Delivers Multi-Mission Capability SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in unmanned aircraft from the iconic Predator® to the YFQ-42A Collaborative Combat Aircraft, has unveiled a new small uncrewed launched effect with widespread multi-mission capabilities for the global aerospace and defense market. Inspired by Pele, the Hawaiian goddess of powerful natural forces in the Pacific, the Precision Exportable Launched Effect - PELE - is a small, attrition-tolerant, propeller-driven unmanned aircraft designed to extend the sensing and other capabilities of a mothership aircraft and its user service. PELE is a semi-autonomous unmanned aircraft system (UAS) with an 11-foot wingspan and 16-horsepower engine that extends user reach within challenging environments with potent effects. PELE also could be launched from the ground. The new PELE is optimized for use on the MQ-9B SkyGuar
GA-ASI Adds Saab Airborne Early Warning Capability to MQ-9B16.6.2025 06:00:00 CEST | Press release
New Capability Will Transform Airborne Early Warning Access and Affordability for MQ-9B Customers SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is partnering with Saab to develop Airborne Early Warning and Control (AEW&C) capability for its line of MQ-9B Remotely Piloted Aircraft, which includes the SkyGuardian® and SeaGuardian® models, the United Kingdom's Protector, and the new MQ-9B STOL (Short Takeoff and Landing) model currently in development. GA-ASI plans to fly AEW on MQ-9B in 2026. "High and low-tech air threats both pose major challenges to global air forces," said GA-ASI President David R. Alexander. "We're developing an affordable AEW solution in cooperation with Saab, the leading provider of AEW&C systems, that will transform our customers' operations against both sophisticated cruise missiles and simple but dangerous drone swarms. We're also making AEW capability possible in areas it doesn't exist today, such as from
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom